PharmaJet® Presents Partner Data Demonstrating that Needle-free Delivery Boosts Immune Response of DNA and Novel Therapeutic Cancer Vaccines Read More » April 17, 2025
Octave Bioscience’s MSDA Test Proven to Provide Clinically Actionable Insights That Drive Meaningful Clinical Decisions in MS Care Read More » April 16, 2025
Pillar Biosciences Receives CMS Coverage for FDA Approved oncoReveal® CDx Pan-Cancer Solid tumor IVD Kit Read More » April 3, 2025
Luxembourg Institute of Health (LIH) and Cytovation AS Advance New Cancer Therapy Towards Clinical Success Read More » April 1, 2025
Sphere Bio Launches Cyto-Cellect Human IgG Kappa and Viability Assay Kit for Efficient Single-cell Selection Read More » March 31, 2025